[1] KALRA A, YETISKUL E, WEHRLE C J, et al.Physiology, liver[M].Treasure Island (FL):StatPearls Publishing,2024. [2] ANDRADE R, LUCENA M.Drug-induced hepatotoxicity[J].Reactions,2003,97:11-12. [3] MICHELOTTI G A, MACHADO M V, DIEHL A M.NAFLD, NASH and liver cancer[J].Nature Reviews Gastroenterology and Hepatology,2013,10(11):656-665. [4] DHAR D, BAGLIERI J, KISSELEVA T, et al.Mechanisms of liver fibrosis and its role in liver cancer[J].Experimental Biology and Medicine,2020,245(2):96-108. [5] SHINGINA A, MUKHTAR N, WAKIM-FLEMING J, et al.Acute liver failure guidelines[J].The American Journal of Gastroenterology,2023,118(7):1128-1153. [6] STOESS C, CHOI Y K, ONYURU J, et al.Cell death in liver disease and liver surgery[J].Biomedicines,2024,12(3):559. [7] GUO Q, JIN Y Z, CHEN X Y, et al.NF-κB in biology and targeted therapy:New insights and translational implications[J].Signal Transduction and Targeted Therapy,2024,9(1):53. [8] GUERRA M T, FONSECA E A, MELO F M, et al.Mitochondrial calcium regulates rat liver regeneration through the modulation of apoptosis[J].Hepatology,2011,54(1):296-306. [9] OLIVA-VILARNAU N, HANKEOVA S, VORRINK S U, et al.Calcium signaling in liver injury and regeneration[J].Frontiers in Medicine,2018,5:192. [10] MOON D O.Calcium′s role in orchestrating cancer apoptosis:Mitochondrial-centric perspective[J].International Journal of Molecular Sciences,2023,24(10):8982. [11] AHMED O, ROBINSON M W, O′FARRELLY C. Inflammatory processes in the liver:Divergent roles in homeostasis and pathology[J].Cellular and Molecular Immunology,2021,18(6):1375-1386. [12] CHEN X Y, ZHANG L, ZHENG L M, et al.Role of Ca2+ channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies[J].International Journal of Molecular Medicine,2022,50(3):113. [13] YUAN H B, LIU Z Q, CHEN M Y, et al.Protein truncating variants in mitochondrial-related nuclear genes and the risk of chronic liver disease[J].BMC Medicine,2024,22(1):239. [14] LIRA CHAVEZ F M, GARTZKE L P, VAN BEUNINGEN F E, et al. Restoring the infected powerhouse:Mitochondrial quality control in sepsis[J].Redox Biology,2023,68:102968. [15] MANGLA A, GUERRA M T, NATHANSON M H.Type 3 inositol 1, 4, 5-trisphosphate receptor:A calcium channel for all seasons[J].Cell Calcium,2020,85:102132. [16] HARRISON P J, HUSAIN S M, LEE H M, et al.CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders:Advances from functional genomics and pharmacoepidemiology[J].Neuropharmacology,2022,220: 109262. |